title: New features, new vessels, and ongoing challenges.
authors.forename: Gary N
authors.initials: GN
authors.lastname: Foulks
mesh_terms: D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D016510:Corneal Neovascularization / Q000188:drug therapy*; D003930:Diabetic Retinopathy / Q000378:metabolism*; D015352:Dry Eye Syndromes / Q000503:physiopathology*; D006801:Humans; D018972:Insulin-Like Growth Factor Binding Protein 3 / Q000378:metabolism*; D007334:Insulin-Like Growth Factor I / Q000378:metabolism; D018434:Sickness Impact Profile; D011795:Surveys and Questionnaires; D013666:Tears / Q000378:metabolism*; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors
chemical_list: D020533:Angiogenesis Inhibitors; C515497:IGFBP3 protein, human; D018972:Insulin-Like Growth Factor Binding Protein 3; C467484:VEGFA protein, human; D042461:Vascular Endothelial Growth Factor A; D007334:Insulin-Like Growth Factor I